Earnings Call · Q4 FY2022·2023-01-25

Q4 22EPS +0.77%·Rev n/aQ3 22EPS +5.31%·Rev n/aQ2 22EPS +3.88%·Rev n/aQ1 22EPS +5.36%·Rev n/a⚠ consensus missing

Elevance Health, Inc. ELV

Steve Tanal — Vice President of Investor Relations

Gail Boudreaux — President and Chief Executive Officer

John Gallina — Chief Financial Officer

+3.6%1d on move date+3.5% vs SPY3d+2.9%5d+4.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ELV calls or request research access.

More ELV calls Browse calls Request research access